A comprehensive and systematic assessment of the current status of genetic association studies (GAS) for osteoarthritis was conducted. Data from 327 GAS involving 187 distinct genetic variants were analyzed and cataloged in CUMAGAS-OSTEO, a Web-based information system (http://biomath.med.uth.gr) that allows the retrieval and synthesis of data from GAS on osteoarthritis. In individual studies, 66 variants (mostly single nucleotide polymorphisms) showed significant associations with osteoarthritis risk. For 19 variants, the association was significant at P < 0.01, with an increased risk greater than 30%. Only 2.4% of studies had statistical power greater than 50% to detect a modest genetic effect. Nineteen variants were investigated by 4 or more studies, and their results were subjected to meta-analysis. Significant associations were derived for 2 variants (GDF5 rs143383, LRCH1 rs912428) in the main meta-analysis and for 2 other variants (TXNDC3 rs4720262, ESR1 rs2234693) in subgroup analysis by ethnicity or osteoarthritic body site. Heterogeneity ranged from none to high. In general, there was consistency of genetic effects across ethnic groups and body sites, and there was no differential magnitude of effect in large studies versus small studies. CUMAGAS-OSTEO may be a useful tool for identifying pertinent geneosteoarthritis associations and providing an updated summary of risk effects.
Osteoarthritis is a group of diseases and mechanical abnormalities entailing degradation of joints, including articular cartilage and the subchondral bone next to it (1) . Osteoarthritis is the most common form of arthritis and is the leading cause of chronic disability in the United States, affecting nearly 27 million people and accounting for 25% of visits to primary care physicians and half of all prescriptions for nonsteroidal antiinflammatory drugs (2) . It is estimated that 80% of the US population will have radiographic evidence of osteoarthritis by age 65 years, although only 60% of those persons will show symptoms (2) .
Osteoarthritis can develop after traumatic injuries in joints. However, a number of studies have shown that there is a greater prevalence of the disease between siblings, especially identical twins, indicating a hereditary basis (3) . It is estimated that 60% of osteoarthritis cases may result from genetic factors (3) .
Genetic association studies represent a popular approach for investigating the genetic etiology of osteoarthritis (4) . The number of published genetic association studies on osteoarthritis has increased rapidly, and this trend is expected to accelerate because of the availability of mapped single nucleotide polymorphisms and advances in genotyping technologies (4) . Considering the exponential accumulation of genetic association data, keeping track of the rapidly growing amount of evidence is a major challenge (5) . The available published evidence on osteoarthritis is weak, owing to inconsistent and inconclusive results from individual studies, mainly attributed to small sample sizes and heterogeneity of studied populations.
In order to explore the involvement of gene variants in osteoarthritis susceptibility and to make available to researchers the genetic risk effect of each variant implicated in osteoarthritis, we systematically searched the literature for all available genetic association studies of primary osteoarthritis and created CUMAGAS-OSTEO (Cumulative MetaAnalysis of Genetic Association Studies-Osteoarthritis), a Web-based information system (http://biomath.med.uth.gr) which allows the retrieval and synthesis of data from genetic association studies in osteoarthritis with the capacity for continuous updating. In this project, we cataloged all retrieved articles and estimated the risk effects for the various genetic models of all individually investigated variants. Finally, we synthesized the available data using meta-analytic techniques in order to increase statistical power for detecting significant results and to decrease the uncertainty of the estimated genetic risk effects (5) .
MATERIALS AND METHODS

Selection of studies
All English-language articles published before July 2009 were identified through extended computer-based searches of the PubMed database (National Library of Medicine). The search criterion used was as follows: (''osteoarthritis'' or ''OA'') and (''gene'' or ''polymorphism'') and (''risk'' or ''association'' or ''susceptibility''). We then read the retrieved articles in their entirety to assess their appropriateness for inclusion in the field synopsis. Articles providing data on the osteoarthritis relation in different populations or at different body sites were considered separate studies. To avoid the inclusion of duplicated data that might have led to overestimation of genetic effects in the final analysis, we carefully appraised and examined the retrieved studies by comparing geographic locations, author names, and study periods to identify overlapping samples. In cases of the same data set or overlapping data sets, we included the results from the study with the largest population.
To be eligible for inclusion, articles had to be peerreviewed articles on genetic association studies that provided the genotypic distribution of the genetic variant in osteoarthritis cases and healthy controls. Only studies on human subjects that had used DNA-based analysis methods for genotyping were considered. Family-based studies were not considered because of different design considerations. Case reports, editorials, and review articles were excluded. Abstracts of retrieved studies were independently read by 2 investigators (D. Z. and G. K.) to assess their appropriateness for this study. The results were compared, and disagreements were resolved by consensus. We also reviewed all references cited in the studies to identify additional published work not indexed by the searched databases.
Data abstraction
From each study, the following information was extracted: name of the first author, year of publication, ethnicity of the study population, body site of osteoarthritis, demographic data, definitions of cases and controls, and numbers of cases and controls for each genotype. In cases, the phenotypic definition of osteoarthritis was based on clinical/symptomatic criteria, radiographic criteria, or joint replacement, as used in the individual studies. Symptomatic osteoarthritis was defined according to the recommendations of the American College of Rheumatology (6), whereas radiographic osteoarthritis was classified according to the Kellgren/Lawrence scale (range, 0-4) (7). Controls were either healthy volunteers (without known status of affected joints other than the one under study) or subjects with no other affected joints (knee, hip, or hand or a combination of them). The frequencies of the alleles and the genotypic distributions were extracted or calculated for both cases and controls. We identified the reference single nucleotide polymorphism identification numbers (rs numbers) and the nucleotide base changes for all genetic variants through extended searches of bioinformatics databases (8) (9) (10) .
Data analysis and synthesis
Prior to meta-analysis, the risk effects of gene variants for the allele contrast (mutant-type allele vs. wild-type allele) and the recessive and dominant models were evaluated for each study separately. All associations are indicated as odds ratios with corresponding 95% confidence intervals.
When 4 or more studies had investigated the same variant, we conducted a meta-analysis of the published results. In the meta-analysis, heterogeneity between studies was tested using the Q statistic and quantified with the I 2 metric (5), which is independent of the number of studies in the meta-analysis. The pooled odds ratio was estimated using the random-effects (DerSimonian and Laird) model (5) . Random-effects modeling assumes genuine diversity in the results of various studies, and it incorporates betweenstudy variance into the calculations. When there is a lack of heterogeneity, the random-effects model coincides with the fixed-effects model (5) . The differential magnitude of effect in large studies versus small studies (of variants included in meta-analysis) was checked for the allele contrast using the test of Harbord et al. (11) . The meta-analysis consisted of the main (overall) analysis, which included all available data, and subgroup analyses by ethnicity and osteoarthritic body site (hip, knee, or hand). When the meta-analysis for a variant included data from only 1 ethnic group, the main analysis coincided with the subgroup analysis for that ethnic group. Specific categories of hand osteoarthritis (first carpometacarpal joint and distal interphalangeal joint) and knee osteoarthritis (tibiofemoral and patellofemoral) were considered in further subanalyses, on the basis of previous evidence indicating that these forms of disease are phenotypically heterogeneous and should be treated as separate clinical entities (12, 13) . Sensitivity analysis, which examines the effect of excluding specific studies, was also conducted (5) .
The distribution of each variant in the control group was tested for Hardy-Weinberg equilibrium. Since lack of Hardy-Weinberg equilibrium indicates possible genotyping errors and/or population stratification, a sensitivity analysis was carried out for these studies (5). We calculated the power of each study for the allele contrast assuming an increase in effect size of 20% (modest effect), a significance level of 0.05, and a minor allele frequency equal to that of the study population (14) . Analyses were performed using CUMAGAS-OSTEO and Compaq Visual Fortran 90 (Visual Numerics, Inc., Denver, Colorado) with the International Mathematics and Statistics Library.
CUMAGAS-OSTEO
CUMAGAS-OSTEO performs meta-analysis for all genetic models (allele contrast, dominant, recessive, and additive) and provides information on study design and gene polymorphism characteristics, including nucleotide-base changes and dbSNP (National Center for Biotechnology Information) rs numbers. CUMAGAS-OSTEO has the capacity for continuous updating (we currently aim to update the system annually), and authors of published studies can contribute new data, correct existing data, or notify the CUMAGAS investigators of missed studies by contacting them at cumagas@med.uth.gr.
RESULTS
Eligible articles
The literature review identified 383 titles that met the search criteria. After abstract selection, 145 articles remained. Sixty-one studies that had investigated the association between genetic variants and osteoarthritis fulfilled the inclusion criteria. Figure 1 shows the numbers of studies 
Studies' characteristics and association results
The characteristics of each study and the association results for variants are shown in Web Table 1 , which is posted on the Journal's Web site (http://aje.oxfordjournals.org/). Studies were conducted in various populations of differing racial descent: 237 studies involved whites, 90 involved East Asians, and 2 involved other ethnic groups. The distribution of genotypes in the control group deviated from HardyWeinberg equilibrium in 14 studies. In 146 studies, there was not enough information to test for Hardy-Weinberg equilibrium. In 2.4% of the studies, statistical power was greater than 50%, and in 12% of the studies, the power ranged from 25% to 50%. Only 1 study had statistical power greater than 80%.
In total, 66 variants showed a significant association with osteoarthritis risk under any genetic model. The association was significant at P < 0.01 for any genetic model with an increased risk (or prevention) of more than 30% in 25 studies investigating 19 variants from 8 genes: A1AT (TaqI), CALM1 (rs3213718), DVWA (rs3773472, rs11713836, rs9864422, rs3773475, rs7639618, rs3773469, rs353093, and rs1287464), FRZB (rs7775), GDF5 (rs143383, rs224331, and rs143384), IL1B (rs1143634), IL1RN (rs454078 and rs315952), and IL6 (rs1800797 and rs1800795).
Meta-analysis results
In total, 19 variants were investigated in 4 or more studies, and their results were subjected to meta-analysis. Table  1 shows the meta-analysis results for the associations between the different variants and the risk of developing osteoarthritis. Significant associations were derived for 4 variants under any genetic model and subgroup analysis. However, in general, the results were based on a relatively small number of studies (2-10 studies), and therefore they should be interpreted with caution.
In the main analyses, significant results were shown for genetic variants in the GDF5 and LRCH1 genes. In particular, a significant association was shown for the allele contrast of the variant GDF5 rs143383, overall (odds ratio (OR) ¼ 0.73, 95% confidence interval (CI): 0.59, 0.90) and by ethnicity (whites-OR ¼ 0.91, 95% CI: 0.84, 0.99; East Asians-OR ¼ 0.63, 95% CI: 0.51, 0.77) and body site (hip-OR ¼ 0.56, 95% CI: 0.48, 0.66; knee-OR ¼ 0.78, 95% CI: 0.64, 0.96). The dominant and recessive models produced similar results (with the exception of the subgroup analysis for whites and the knee for the dominant model). A significant result was also shown for the variant LRCH1 rs912428, overall, for the allele contrast and the recessive model (OR ¼ 1.17 (95% CI: 1.03, 1.34) and OR ¼ 1.39 (95% CI: 1.05, 1.85), respectively). The subgroup analysis for whites produced similar results.
In subgroup analysis by ethnicity, the variant TXNDC3 rs4720262 produced a significant association for East Asians (allele contrast-OR ¼ 0.78, 95% CI: 0.62, 0.97; dominant model-OR ¼ 0.76, 95% CI: 0.60, 0.97). Finally, in the subgroup analysis for hip osteoarthritis, the variant ESR1 rs2234693 showed a significant association for the allele contrast and the dominant model (OR ¼ 0.87 (95% CI: 0.78, 0.97) and OR ¼ 0.82 (95% CI: 0.70, 0.97), respectively).
In the rest of the meta-analyses, no significant associations were detected in the main or subgroup analyses, and there was consistency of genetic effects across ethnic groups and body sites. The genotype distribution among controls deviated from Hardy-Weinberg equilibrium in only 2 of the studies included in the meta-analyses. Both studies had examined the variant IL1RN rs1794068. In sensitivity analyses excluding these 2 studies, the pattern of results was not altered. In the overall meta-analyses, there was a differential magnitude of effect in large studies versus small studies for 4 variants:
DISCUSSION
To our knowledge, our project represents the first comprehensive and systematic assessment of the current status of genetic epidemiology research on osteoarthritis. Our primary endeavor was to synthesize the currently available data on the genetics of osteoarthritis and assess comprehensively the involvement of gene variants in the development of the disease. Data from 327 genetic association studies described in 61 published articles were cataloged in a publicly available Web-based database and information system, CUMAGAS-OSTEO. With the implementation of CUMAGAS-OSTEO, summary effect estimates were calculated in the context of 19 meta-analyses for genetic variants and risk of osteoarthritis. The resulting evidence provides insights regarding the role of numerous candidate genes in osteoarthritis susceptibility.
Most published genetic association studies on osteoarthritis are underpowered in terms of their ability to detect the minor contributing role of common alleles. Indeed, the most realistic genetic association between a polymorphic locus and a disease has been claimed to yield an odds ratio of 1.1-1.5 (4, 15) . Therefore, to achieve satisfactory statistical power (>80%) to identify a modest genetic effect (OR ¼ 1.2) of a polymorphism present in 10% of individuals, a sample size of 10,000 subjects or more would be needed for a genetic association study. Meta-analysis clearly has a role in offering an analysis with the potential for greater statistical power through pooling of the results of independent analyses (5). In the CUMAGAS-OSTEO database, significant associations were shown in the main analyses for the rs143383 variant of the GDF5 gene and the rs912428 variant of the LRCH1 gene. A previous meta-analysis on the GDF5 rs143383 variant by Chapman et al. (16) showed that the overall (all osteoarthritis) risk effect was not significant in Europeans but became significant in the combined European and Asian studies, though with large heterogeneity. A more recent meta-analysis by Evangelou et al. (17) that also included unpublished data showed nonsignificant effects when data from all studies were combined but revealed consistent site-specific associations (knee osteoarthritis). Consequently, none of the significant associations revealed in the present main meta-analyses can be considered sufficiently strong; thus, it is unlikely that these significant findings will be replicated in the future. The TXNDC3 rs4720262 and ESR1 rs2234693 variants produced significant results in the context of subgroup analysis for East Asians and hip osteoarthritis, respectively. However, the results were based on very small numbers of studies, and therefore they should be interpreted with caution. Although 66 variants (20%) had shown significant effects in individual studies, none of the 15 remaining meta-analyses detected any significant association. This lack of positive signals with strong credibility should be viewed in the light of the inherent weaknesses of genetic epidemiology investigations (5) .
Since the requirements for sample sizes will be far beyond what is currently available and no single institution alone will be able to provide a reasonable number of patients, the creation of large databases and consortia to facilitate the sharing of resources among investigators would be a straightforward step. The need for data-sharing has been highlighted by the Genetic Association Information Network (GAIN) initiative (18) , created with the aim of facilitating the subsequent and joint analysis of genome-wide data. The premise of such collaborative efforts has recently been realized (19) .
The reliability of the candidate gene approach for elucidating the complex genetic architecture of osteoarthritis is questioned, given the lack of consistently replicated associations overall. The 2 large-scale genome-wide association studies with extensive coverage provided ''hypothesis-free'' evidence for low-risk variants predisposing people to osteoarthritis (19, 20) . Previously unsuspected loci in the A2BP1 and PTGS2 genes were discovered and results were replicated in independent cohorts, highlighting novel pathogenic mechanisms. Although the results of these genomic scans have not yet become publicly available (21, 22) , incorporation of such results into an information system like CUMAGAS-OSTEO will enable the integration of evidence resulting from ''hypothesis-free'' studies with the candidategene approach (15, 23) .
The phenotypic heterogeneity of osteoarthritis in the studies included in our synopsis makes our effort to meaningfully combine the findings of genetic association studies in the complex field of osteoarthritis an extremely tough task (24) . Thus, in the presence of such large heterogeneity, the results should be interpreted with caution. There may be fundamental differences in the nature of osteoarthritis genetic susceptibility between affected sites or between the 2 sexes (24). Accurate standardized definitions in independent cohorts recruited in the context of consortial efforts are needed.
Furthermore, environmental factors, particularly nutrients, have to be accurately evaluated together with complex genotyping, in order to weight their importance in masking or unmasking functional variants with respect to a specific genetic background (25, 26) . Our analysis used the available study-level allele and genotype distributions, precluding adjusted analysis for potential gene-gene and geneenvironment interactions, for which raw genotype data would be required. Failure to account for interactions may have reduced the power of our analysis but is unlikely to have inflated the number of positive results.
CUMAGAS-OSTEO represents an evidence-based approach combined with an electronic information system with which to systematically search, review, and synthesize the rapidly emerging body of genetic association studies on osteoarthritis, with the capacity for continuous updating. Available evidence is cataloged and, where appropriate, synthesized with meta-analytic techniques, highlighting the strengths as well as the gaps of research in the field. CUMAGAS is being expanded to additional complex phenotypes (14, 27) ; it will incorporate the findings from emerging genome-wide association studies and will be updated on an annual basis as evidence accumulates. CUMAGAS-OSTEO has the appropriate architecture to store, analyze, and meta-analyze data from genome-wide association studies. However, integration of genome-wide association studies will depend on the public availability of their data.
In summary, apart from the GDF5 and LRCH1 genes, there is no evidence from these meta-analyses of an association between genetic variants and the risk of developing osteoarthritis. Collaborative research in osteoarthritis may help in identifying the contributing role of variants through the performance of candidate-gene and genome-wide studies with adequate power. Furthermore, the design of rigorous studies for investigating epistatic and gene-environment interactions and the utilization of data generated by genomic studies may help in deriving more conclusive claims about the genetics of osteoarthritis. The CUMAGAS-OSTEO information system may be a useful resource for reviewing and interpreting the findings of accumulating genomic epidemiology research in osteoarthritis.
